This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Unlock ways to earn travel points on no fee cards. Boost your rewards and make the most of your travel expenses effortlessly.
17,323 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Animoca Brands announces a strategic investment in the AVAX token and a partnership with Ava Labs to accelerate Avala...
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
When a public figure is pulled into a legal crisis, money can follow the headlines. This article breaks down how the ...
The Treasury issued a general license for energy aboard vessels, unlocking up to 140 million barrels. Markets weigh t...
Crypto markets have cooled, and Solana stands out with speed and lower fees. This guide weighs the bear and bull case...
Arm is venturing into silicon design after decades as a licensing powerhouse. This bold shift could impact AI data ce...
A Reynolds director recently bought about $99,000 of REYN stock. This article breaks down what reynolds stock directo...
Volatility is real and headlines can be alarming. Yet many individual investors continue to buy stocks. This guide ex...
Ark Invest disclosed a new Alphabet stake, triggering debate over Google’s growth drivers and the broader tech rally....
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
Investors are debating whether Microsoft stock is undervalued. This guide breaks down the fundamentals, growth cataly...